SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-021713
Filing Date
2021-02-12
Accepted
2021-02-12 14:35:54
Documents
2
Group Members
BPIFRANCE S.A.CAISSE DES DEPOTSEPIC BPIFRANCE

Document Format Files

Seq Description Document Type Size
1 SC 13D tm216133d4_sc13d.htm SC 13D 117017
2 EXHIBIT 99.1 tm216133d4_ex99-1.htm EX-99.1 7955
  Complete submission text file 0001104659-21-021713.txt   126663
Mailing Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710
Business Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710 33153898789
Bpifrance Participations SA (Filed by) CIK: 0001581835 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Subject) CIK: 0001598599 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91173 | Film No.: 21625864
SIC: 2836 Biological Products, (No Diagnostic Substances)